Single-cell transcriptomic atlas-guided development of CAR-T cells for the treatment of acute myeloid leukemia.


Journal

Nature biotechnology
ISSN: 1546-1696
Titre abrégé: Nat Biotechnol
Pays: United States
ID NLM: 9604648

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 30 03 2022
accepted: 20 01 2023
medline: 13 11 2023
pubmed: 15 3 2023
entrez: 14 3 2023
Statut: ppublish

Résumé

Chimeric antigen receptor T cells (CAR-T cells) have emerged as a powerful treatment option for individuals with B cell malignancies but have yet to achieve success in treating acute myeloid leukemia (AML) due to a lack of safe targets. Here we leveraged an atlas of publicly available RNA-sequencing data of over 500,000 single cells from 15 individuals with AML and tissue from 9 healthy individuals for prediction of target antigens that are expressed on malignant cells but lacking on healthy cells, including T cells. Aided by this high-resolution, single-cell expression approach, we computationally identify colony-stimulating factor 1 receptor and cluster of differentiation 86 as targets for CAR-T cell therapy in AML. Functional validation of these established CAR-T cells shows robust in vitro and in vivo efficacy in cell line- and human-derived AML models with minimal off-target toxicity toward relevant healthy human tissues. This provides a strong rationale for further clinical development.

Identifiants

pubmed: 36914885
doi: 10.1038/s41587-023-01684-0
pii: 10.1038/s41587-023-01684-0
pmc: PMC7615296
mid: EMS163133
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1618-1632

Subventions

Organisme : European Research Council
ID : 756017
Pays : International

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Nature America, Inc.

Références

Leukemia. 2015 Apr;29(4):828-38
pubmed: 25322685
PLoS One. 2015 Apr 20;10(3):e0121314
pubmed: 25894527
Science. 2012 Dec 21;338(6114):1593-9
pubmed: 23258891
Cell Death Differ. 2010 Dec;17(12):1917-27
pubmed: 20489731
Front Cell Neurosci. 2020 Aug 06;14:198
pubmed: 32848611
Exp Hematol. 2002 Feb;30(2):126-34
pubmed: 11823047
Nat Med. 2021 Mar;27(3):546-559
pubmed: 33654293
Nat Biomed Eng. 2021 Nov;5(11):1246-1260
pubmed: 34083764
N Engl J Med. 2018 Feb 1;378(5):439-448
pubmed: 29385370
Curr Treat Options Oncol. 2020 Jun 29;21(8):66
pubmed: 32601974
Nat Immunol. 2020 Mar;21(3):343-353
pubmed: 32066951
Nature. 2020 Nov;587(7835):619-625
pubmed: 33208946
Genome Biol. 2021 Aug 25;22(1):248
pubmed: 34433466
PLoS One. 2011;6(10):e26317
pubmed: 22046273
Cell. 2020 Oct 1;183(1):126-142.e17
pubmed: 32961131
Mol Syst Biol. 2021 Mar;17(3):e9923
pubmed: 33749993
J Immunol. 1998 Jun 1;160(11):5390-6
pubmed: 9605139
N Engl J Med. 2018 Jul 5;379(1):64-73
pubmed: 29972754
Nature. 2020 May;581(7808):303-309
pubmed: 32214235
Proc Natl Acad Sci U S A. 2018 Nov 13;115(46):E10988-E10997
pubmed: 30373828
Cell Rep. 2018 Oct 23;25(4):871-883
pubmed: 30355494
Genome Biol. 2018 Feb 6;19(1):15
pubmed: 29409532
Cancer Discov. 2021 Nov;11(11):2748-2763
pubmed: 34266984
PLoS One. 2015 Mar 20;10(3):e0120925
pubmed: 25793878
Semin Cancer Biol. 2020 Oct;65:80-90
pubmed: 31705998
Blood Adv. 2020 Apr 14;4(7):1419-1431
pubmed: 32271901
Nat Methods. 2019 Dec;16(12):1289-1296
pubmed: 31740819
Science. 2017 May 26;356(6340):
pubmed: 28495876
Nature. 2019 Nov;575(7783):512-518
pubmed: 31597160
Mol Neurodegener. 2018 Dec 22;13(1):67
pubmed: 30577865
Blood. 2018 Dec 6;132(23):2484-2494
pubmed: 30275109
Proc Natl Acad Sci U S A. 1996 Mar 19;93(6):2588-92
pubmed: 8637918
Nat Commun. 2019 Aug 14;10(1):3660
pubmed: 31413257
Nat Commun. 2020 May 8;11(1):2285
pubmed: 32385277
Leukemia. 2018 May;32(5):1168-1179
pubmed: 29472720
Haematologica. 2019 Jul;104(7):1302-1308
pubmed: 31221785
N Engl J Med. 2013 May 30;368(22):2059-74
pubmed: 23634996
Cell. 2019 Mar 7;176(6):1265-1281.e24
pubmed: 30827681
Annu Rev Immunol. 2014;32:367-402
pubmed: 24471431
Genome Biol. 2019 Dec 31;21(1):1
pubmed: 31892341
Genome Med. 2017 Aug 18;9(1):75
pubmed: 28821273
Nat Med. 2019 Sep;25(9):1341-1355
pubmed: 31501612
Blood Adv. 2017 Nov 16;1(25):2307-2319
pubmed: 29296880
J Immunol Methods. 2019 Dec;475:112429
pubmed: 29530508
Blood. 2013 Nov 14;122(20):3461-72
pubmed: 24016461
Mol Cell. 2019 Jul 11;75(1):7-12
pubmed: 31299208
Hum Gene Ther. 2009 Sep;20(9):966-74
pubmed: 19453219
Blood. 2019 Feb 7;133(6):588-599
pubmed: 30425048
Mol Ther. 2013 Apr;21(4):904-12
pubmed: 23423337
Oncoimmunology. 2020 Aug 15;9(1):1806009
pubmed: 32923168
Clin Cancer Res. 2005 Aug 15;11(16):5708-17
pubmed: 16115907
Drugs. 2017 Jul;77(11):1221-1233
pubmed: 28608166
Leukemia. 2021 Nov;35(11):3282-3286
pubmed: 33833386
Nat Methods. 2017 Oct;14(10):955-958
pubmed: 28846088
Leukemia. 2021 Aug;35(8):2243-2257
pubmed: 33414484
Lancet Oncol. 2015 Aug;16(8):949-56
pubmed: 26179200
F1000Res. 2016 Aug 31;5:2122
pubmed: 27909575
N Engl J Med. 2019 Jan 3;380(1):45-56
pubmed: 30501490
J Exp Clin Cancer Res. 1998 Sep;17(3):251-8
pubmed: 9894758
Blood. 1994 Nov 15;84(10):3261-82
pubmed: 7524733
Neuron. 2019 Sep 4;103(5):820-835.e7
pubmed: 31301936
Blood. 2019 Feb 14;133(7):697-709
pubmed: 30463995
Science. 2019 Sep 27;365(6460):1461-1466
pubmed: 31604275
Genome Biol. 2016 Apr 27;17:75
pubmed: 27122128
Sci Transl Med. 2017 Jul 19;9(399):
pubmed: 28724573
N Engl J Med. 2019 May 2;380(18):1726-1737
pubmed: 31042825
Nat Commun. 2018 Oct 22;9(1):4383
pubmed: 30348985
Front Oncol. 2021 Mar 25;11:654817
pubmed: 33842370
Cancer Cell. 2021 Dec 13;39(12):1558-1559
pubmed: 34678153
Cancer Cell. 2017 Oct 9;32(4):506-519.e5
pubmed: 29017060
Blood. 2021 Jul 29;138(4):318-330
pubmed: 34323938
Semin Hematol. 2019 Apr;56(2):155-163
pubmed: 30926092
Cancer Discov. 2017 Dec;7(12):1404-1419
pubmed: 29025771
Bioinformatics. 2020 Feb 1;36(3):964-965
pubmed: 31400197
Nat Methods. 2014 Apr;11(4):436-42
pubmed: 24562423
Blood. 2021 Nov 11;138(19):1830-1842
pubmed: 34289026
Oncogene. 1995 Dec 21;11(12):2469-76
pubmed: 8545103
Exp Hematol. 2007 Oct;35(10):1538-49
pubmed: 17889721
Nucleic Acids Res. 2020 Jan 8;48(D1):D77-D83
pubmed: 31665515
Science. 2015 May 8;348(6235):648-60
pubmed: 25954001
Leukemia. 2020 Oct;34(10):2688-2703
pubmed: 32358567
Nat Commun. 2017 Jan 16;8:14049
pubmed: 28091601
Mol Syst Biol. 2021 Jan;17(1):e9620
pubmed: 33491336
Nat Biotechnol. 2020 Feb;38(2):233-244
pubmed: 31907405
Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082
pubmed: 29126136
Nat Protoc. 2020 Apr;15(4):1484-1506
pubmed: 32103204
Am J Respir Crit Care Med. 2019 Jun 15;199(12):1517-1536
pubmed: 30554520
Proc Natl Acad Sci U S A. 2019 Nov 26;116(48):24275-24284
pubmed: 31712432
Mol Ther. 2017 Sep 6;25(9):2202-2213
pubmed: 28676343
EMBO J. 2022 Feb 15;41(4):e109108
pubmed: 35019161

Auteurs

Adrian Gottschlich (A)

Division of Clinical Pharmacology, University Hospital, LMU Munich, Member of the German Center for Lung Research (DZL), Munich, Germany.
Bavarian Cancer Research Center (BZKF), Munich, Germany.
Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.

Moritz Thomas (M)

Institute of AI for Health, Helmholtz Munich, Neuherberg, Germany.
School of Life Sciences Weihenstephan, Technical University of Munich, Freising, Germany.

Ruth Grünmeier (R)

Division of Clinical Pharmacology, University Hospital, LMU Munich, Member of the German Center for Lung Research (DZL), Munich, Germany.

Stefanie Lesch (S)

Division of Clinical Pharmacology, University Hospital, LMU Munich, Member of the German Center for Lung Research (DZL), Munich, Germany.

Lisa Rohrbacher (L)

Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.
Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany.

Veronika Igl (V)

Division of Clinical Pharmacology, University Hospital, LMU Munich, Member of the German Center for Lung Research (DZL), Munich, Germany.

Daria Briukhovetska (D)

Division of Clinical Pharmacology, University Hospital, LMU Munich, Member of the German Center for Lung Research (DZL), Munich, Germany.

Mohamed-Reda Benmebarek (MR)

Division of Clinical Pharmacology, University Hospital, LMU Munich, Member of the German Center for Lung Research (DZL), Munich, Germany.

Binje Vick (B)

Research Unit Apoptosis in Hematopoietic Stem Cells, Helmholtz Munich, German Research Center for Environmental Health (HMGU), Munich, Germany.
Department of Pediatrics, University Hospital, LMU Munich, Munich, Germany.

Sertac Dede (S)

Department of Neurology, University Hospital, LMU Munich, Munich, Germany.

Katharina Müller (K)

Department of Neurology, University Hospital, LMU Munich, Munich, Germany.

Tao Xu (T)

Department of Neurology, University Hospital, LMU Munich, Munich, Germany.

Dario Dhoqina (D)

Division of Clinical Pharmacology, University Hospital, LMU Munich, Member of the German Center for Lung Research (DZL), Munich, Germany.

Florian Märkl (F)

Division of Clinical Pharmacology, University Hospital, LMU Munich, Member of the German Center for Lung Research (DZL), Munich, Germany.

Sophie Robinson (S)

Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.
Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.

Andrea Sendelhofert (A)

Institute of Pathology, LMU Munich, Munich, Germany.

Heiko Schulz (H)

Institute of Pathology, LMU Munich, Munich, Germany.

Öykü Umut (Ö)

Division of Clinical Pharmacology, University Hospital, LMU Munich, Member of the German Center for Lung Research (DZL), Munich, Germany.

Vladyslav Kavaka (V)

Institute of Clinical Neuroimmunology, University Hospital, LMU Munich, Munich, Germany.
Biomedical Center (BMC), Faculty of Medicine, LMU Munich, Martinsried, Germany.

Christina Angeliki Tsiverioti (CA)

Division of Clinical Pharmacology, University Hospital, LMU Munich, Member of the German Center for Lung Research (DZL), Munich, Germany.

Emanuele Carlini (E)

Division of Clinical Pharmacology, University Hospital, LMU Munich, Member of the German Center for Lung Research (DZL), Munich, Germany.

Sayantan Nandi (S)

Division of Clinical Pharmacology, University Hospital, LMU Munich, Member of the German Center for Lung Research (DZL), Munich, Germany.

Thaddäus Strzalkowski (T)

Division of Clinical Pharmacology, University Hospital, LMU Munich, Member of the German Center for Lung Research (DZL), Munich, Germany.

Theo Lorenzini (T)

Division of Clinical Pharmacology, University Hospital, LMU Munich, Member of the German Center for Lung Research (DZL), Munich, Germany.

Sophia Stock (S)

Division of Clinical Pharmacology, University Hospital, LMU Munich, Member of the German Center for Lung Research (DZL), Munich, Germany.
Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.
German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.

Philipp Jie Müller (PJ)

Division of Clinical Pharmacology, University Hospital, LMU Munich, Member of the German Center for Lung Research (DZL), Munich, Germany.

Janina Dörr (J)

Division of Clinical Pharmacology, University Hospital, LMU Munich, Member of the German Center for Lung Research (DZL), Munich, Germany.

Matthias Seifert (M)

Division of Clinical Pharmacology, University Hospital, LMU Munich, Member of the German Center for Lung Research (DZL), Munich, Germany.

Bruno L Cadilha (BL)

Division of Clinical Pharmacology, University Hospital, LMU Munich, Member of the German Center for Lung Research (DZL), Munich, Germany.

Ruben Brabenec (R)

Division of Clinical Pharmacology, University Hospital, LMU Munich, Member of the German Center for Lung Research (DZL), Munich, Germany.
Institute of AI for Health, Helmholtz Munich, Neuherberg, Germany.

Natalie Röder (N)

Division of Clinical Pharmacology, University Hospital, LMU Munich, Member of the German Center for Lung Research (DZL), Munich, Germany.

Felicitas Rataj (F)

Division of Clinical Pharmacology, University Hospital, LMU Munich, Member of the German Center for Lung Research (DZL), Munich, Germany.

Manuel Nüesch (M)

Division of Clinical Pharmacology, University Hospital, LMU Munich, Member of the German Center for Lung Research (DZL), Munich, Germany.

Franziska Modemann (F)

Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald University Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Mildred Scheel Cancer Career Center, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf Hamburg, Hamburg, Germany.

Jasmin Wellbrock (J)

Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald University Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Walter Fiedler (W)

Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald University Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Christian Kellner (C)

Division of Transfusion Medicine, Cell Therapeutics and Haemostaseology, University Hospital, LMU Munich, Munich, Germany.

Eduardo Beltrán (E)

Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
Institute of Clinical Neuroimmunology, University Hospital, LMU Munich, Munich, Germany.
Biomedical Center (BMC), Faculty of Medicine, LMU Munich, Martinsried, Germany.

Tobias Herold (T)

Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.
German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.

Dominik Paquet (D)

Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.
Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.

Irmela Jeremias (I)

Research Unit Apoptosis in Hematopoietic Stem Cells, Helmholtz Munich, German Research Center for Environmental Health (HMGU), Munich, Germany.
Department of Pediatrics, University Hospital, LMU Munich, Munich, Germany.
German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.

Louisa von Baumgarten (L)

German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
Department of Neurosurgery, LMU Munich, Munich, Germany.

Stefan Endres (S)

Division of Clinical Pharmacology, University Hospital, LMU Munich, Member of the German Center for Lung Research (DZL), Munich, Germany.
German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Munich, Research Center for Environmental Health (HMGU), Neuherberg, Germany.

Marion Subklewe (M)

Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.
Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany.
German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.

Carsten Marr (C)

Institute of AI for Health, Helmholtz Munich, Neuherberg, Germany.

Sebastian Kobold (S)

Division of Clinical Pharmacology, University Hospital, LMU Munich, Member of the German Center for Lung Research (DZL), Munich, Germany. sebastian.kobold@med.uni-muenchen.de.
German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany. sebastian.kobold@med.uni-muenchen.de.
Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Munich, Research Center for Environmental Health (HMGU), Neuherberg, Germany. sebastian.kobold@med.uni-muenchen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH